Recent Posts / View All Posts

LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS

| Dilumen, Lumendi, News, Press Release, Uncategorized | No Comments
LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS Primary Study Endpoint Reached with no Serious Adverse Events WESTPORT, CONNECTICUT, November 16, 2017 – Connecticut-based medical device innovator Lumendi, LLC...

LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S.

| Dilumen, Lumendi, News, Press Release, Uncategorized | No Comments
LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S. Lumendi Submits Premarket Notification to US FDA For DiLumen C2™ and the DiLumen Is™ as Part...

LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY

| Lumendi, News, Press Release, staff, Uncategorized | No Comments
LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY Dr. Sergey V. Kantsevoy, Professor Alessandro Repici and Professor Kazuki Sumiyama to help guide improvements in endoscopic interventions...

LUMENDI EXPANDS SOCIAL MEDIA PRESENCE

| Dilumen, News, Press Release | No Comments
LUMENDI EXPANDS SOCIAL MEDIA PRESENCE WITH NEW YOU TUBE CHANNEL DEDICATED TO ITS DILUMEN™ EIP WESTPORT, CONNECTICUT, October 4, 2017 – Lumendi, LLC (http:/lumendi.com), a wholly owned subsidiary of Lumendi,...